Education

Johnson & Johnson is taking a bold step in mental health treatment! The pharmaceutical giant has submitted an application to the FDA to allow its ketamine-based drug, Spravato, to be used as a standalone therapy for treatment-resistant depression. This could change the game for those struggling with challenging-to-treat depression. Discover the potential impact of this…

Is the booming sleep industry truly delivering better rest? Join sleep expert Dr. Michael Breus in a captivating discussion about the rise of insomnia, the impact of modern lifestyle on sleep patterns, and practical solutions to improve your sleep quality. Discover fascinating insights into your unique sleep needs and whether the latest gadgets are worth…

Get ready for an unforgettable week as the Democratic National Convention kicks off in Chicago! With an all-star lineup of celebrity hosts and musical performances, the political stage will come alive like never before. Discover how the party is rallying behind Vice President Kamala Harris and what surprises await in the evening programming that runs…

During a recent Democratic National Convention, Hillary Clinton championed Kamala Harris as a powerful contender to shatter the glass ceiling of the presidency. Reflecting on her own historic campaign, Clinton inspired hope for a future where Harris could lead as the first female president. As the political landscape evolves, what challenges and opportunities await female…

Johnson & Johnson is taking a bold step in the fight against treatment-resistant depression by seeking FDA approval to use its ketamine-based drug, Spravato, as a standalone therapy. With promising trial results showing swift symptom relief, the stakes are high for individuals battling this challenging condition. What could this mean for the future of mental…

At 82 years old and facing health challenges, the Rev. Jesse L. Jackson Sr. made a notable appearance at the Democratic National Convention, receiving a heartfelt standing ovation. Discover his significant contributions to civil rights and the Democratic Party, as well as the legacy of his historic presidential campaigns. What does his journey reveal about…

Get ready for a captivating journey into the world of creativity with the premiere of “BEYOND THE CANVAS.” Season three invites viewers to explore the profound impact of art on our lives, featuring an array of talented individuals from surfers to trailblazing artists. Each episode promises to uncover new narratives that highlight how art shapes…

Phil Donahue, a pioneering force in daytime television, has passed away at 88 after a long illness. His groundbreaking show transformed the talk show landscape, taking on serious issues with a unique blend of warmth and assertiveness. Discover the legacy of a man who dared to challenge societal norms and engage deeply with his audience.

Johnson & Johnson is making a bold move to expand the use of its innovative ketamine-based drug, Spravato, seeking FDA approval for it to be a standalone treatment for those battling treatment-resistant depression. With promising results showing relief within 24 hours, the implications for millions of sufferers are significant. Dive into the details of this…

Selom Ametepe, a dedicated doctoral candidate in Cell and Molecular Biology, has been honored with the prestigious DeLill Nasser Travel Award. This recognition not only celebrates her remarkable contributions to genetics but also provides crucial support for her research and professional development. Delve into her inspiring journey and learn how she plans to leverage this…

Selom Ametepe, an international doctoral candidate, has garnered prestigious recognition with the DeLill Nasser Travel Award from the Genetics Society of America. This award will propel her research in cell and molecular biology, enabling her to attend significant conferences and enhance her skills. Dive into Ametepe’s inspiring journey from Togo to groundbreaking genetic research and…

Selom Ametepe, a dedicated doctoral candidate, has been awarded the prestigious DeLill Nasser Travel Award for her outstanding contributions to genetics research. This recognition opens doors for her to attend pivotal conferences and enhance her skills. Discover how her journey from Togo to groundbreaking research in the nervous system of fruit flies is set to…

Selom Ametepe, an inspiring doctoral candidate, has been awarded the DeLill Nasser Travel Award for her groundbreaking work in genetics. This prestigious recognition will support her attendance at major conferences worldwide and advance her research on the nervous system. Discover how her journey from Togo to a leading U.S. university is shaping the future of…

Johnson & Johnson is taking a significant step in the fight against treatment-resistant depression by seeking FDA approval for Spravato as a standalone therapy. This groundbreaking ketamine-based nasal spray could offer hope to millions who struggle with persistent depression. What does this mean for the future of mental health treatment? Discover the details and implications…

Johnson & Johnson is making a bold move in the fight against treatment-resistant depression by seeking FDA approval for Spravato as a standalone therapy. This ketamine-based medication could offer hope to millions who struggle with severe depression, promising symptom relief in just 24 hours. Discover the potential impact of this groundbreaking development in mental health…

Johnson & Johnson is making strides in the fight against treatment-resistant depression by seeking FDA approval to use its ketamine-based medication, Spravato, as a standalone therapy. With a significant portion of the 280 million individuals living with major depressive disorder not finding relief from conventional treatments, this could be a game-changer. Discover how this innovative…

Johnson & Johnson is taking a bold step to redefine treatment-resistant depression by seeking FDA approval to use its ketamine-based drug, Spravato, as a standalone therapy. With promising results showing rapid relief from symptoms, could this be a game-changer for the millions struggling with ineffective treatments? Discover the potential implications of this new application and…

Johnson & Johnson is taking a significant step in the fight against treatment-resistant depression. They’ve submitted a request to the FDA to expand the use of their ketamine-derived medication, Spravato, allowing it to be used independently for patients who struggle with conventional treatments. What does this mean for the millions affected by depression? The latest…

Columbia University is set for a leadership change as President Minouche Shafik announces her resignation amid recent campus unrest. Shafik reflects on her tenure and the challenges faced, while the university prepares for a new chapter. What does this mean for the future of Columbia? Find out more in our full article.

In a surprising turn of events, Columbia University’s President Minouche Shafik has announced her resignation amid significant campus protests and scrutiny over the university’s recent actions. As the first female president of the institution, her tenure has been marked by both progress and challenges. What does this mean for the future of Columbia? Dive into…

Johnson & Johnson is making strides in the fight against depression by proposing a standalone treatment for patients with treatment-resistant depression using their ketamine-based medication, Spravato. With promising clinical trial results suggesting rapid symptom relief, this development could redefine approaches to managing this challenging condition. Could this be a game-changer for the millions struggling with…